Med. praxi. 2024;21(5):270-275 | DOI: 10.36290/med.2024.032

New trends in asthma treatment

MUDr. Tomáš Balner, doc. MUDr. Jaromír Bystroň, CSc.
Oddělení alergologie a klinické imunologie FN Ostrava a Lékařská fakulta Ostravské univerzity, Ostrava

Bronchial asthma is one of the most commonly occurring chronic inflammatory single-molecule diseases worldwide. In recent years, there have been significant advances in asthma research that have contributed to the development of new and more effective therapeutic strategies. The author provides an up-to-date review of the diagnosis, treatment, care, and principles of personalized medicine in asthmatic patients.

Keywords: bronchial asthma, diagnostics, treatment.

Received: July 31, 2024; Accepted: September 4, 2024; Published: December 2, 2024  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Balner T, Bystroň J. New trends in asthma treatment. Med. praxi. 2024;21(5):270-275. doi: 10.36290/med.2024.032.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Purchase PDF

    References

    1. Teřl M, Sedlák V, Krčmová I, et al. Doporučený postup diagnostiky a léčby těžkého astmatu. Geum. 1. vydánî; 2023. ISBN 978-80-87969-64-9.
    2. Bystroň J. Novinky v léčbě průduškového astmatu. Medicína & umění. 2023;3-4(76-77):9-12.
    3. Bystroň J, Heller L, Ostrčilová H, et al. Příspěvek k etiologii, klasifikaci a léčbě těžkého průduškovéhon astmatu. Alergie. 2010;12(3):173-178.
    4. Bousquet J, Vignola AM, Demoly P. Links between rhinitis and asthma. Allergy. 2003 Aug;58(8):691-706. doi: 10.1034/j.1398-9995.2003.00105.x. PMID: 12859545. Go to original source... Go to PubMed...
    5. Coates AL, Wanger J, Cockcroft DW, et al. ERS technical standard on bronchial challenge testing: General considerations and performance of methacholine challenge tests. Eur Respir J. 2017;49(5):1-17. Go to original source... Go to PubMed...
    6. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26:948-68. Go to original source... Go to PubMed...
    7. Fitzpatrick AM, Chipps BE, Holguin F, et al. T2-"Low" Asthma: Overview and Management Strategies. J Allergy Clin Immunol Pract. 2020;8(2):452-63. Go to original source... Go to PubMed...
    8. Schleich FN, Chevremont A, Paulus V, et al. Importance of concomitant local and systemic eosinophilia in uncontrolled asthma. Eur Respir J. 2014;44(1):97-108. Go to original source... Go to PubMed...
    9. Diamant Z, Vijverberg S, Alving K, et al. Toward clinically applicable biomarkers for asthma: An EAACI position paper. Allergy. 2019;74(10):1835-51. Go to original source... Go to PubMed...
    10. Woodruff PG, Modrek B, Choy DF, et al. T-helper Type 2-driven Inflammation Defines Major Subphenotypes of Asthma. Am J Respir Crit Care Med. 2009;180(5):388-95. Go to original source... Go to PubMed...
    11. Miranda C, Busacker A, Balzar S, et al. Distinguishing severe asthma phenotypes: role of age at onset and eosinophilic inflammation. J Allergy Clin Immunol. 2004;113(1):101-8. Go to original source... Go to PubMed...
    12. Kaur R, Chupp G. Phenotypes and endotypes of adult asthma: Moving toward precision medicine. J Allergy Clin Immunol. 2019;144(1):1-12. Go to original source... Go to PubMed...
    13. Breiteneder H, Peng Y-Q, Agache I, et al. Biomarkers for diagnosis and prediction of therapy responses in allergic diseases and asthma. Allergy. 2020;75(12):3039-68. Go to original source... Go to PubMed...
    14. Chung KF, Wenzel SE, Brozek JL, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43:343-73. Go to original source... Go to PubMed...
    15. Global Initiative for Asthma Management and Prevention [Internet]. Global Initiative for Asth-ma - GINA. Available from: https://ginasthma.org/.

    Return to the content


    Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.